mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.006 |